Le Lézard
Classified in: Health
Subject: ANNUAL MEETINGS

Maple Leaf Green World Inc. Announces Voting Results from Annual General Meeting Regarding Nominated Directors


CALGARY, Alberta, July 03, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. ("Maple Leaf" or the "Company") (NEO:MGW) (OTCQB:MGWFF) announces the voting results from its annual general meeting of shareholders held on June 29, 2018 in Calgary, Alberta. A total of 34,861,497 common shares of Maple Leaf ("Common Shares") were represented at the meeting, being 23.115% of the Company's issued and outstanding Common Shares. Each of the director nominees proposed by management were elected as directors of the Company. Detailed results of the votes cast by ballot for directors of the Company at the annual general meeting of shareholders are shown below:

    
NomineesVotes in FavourVotes WithheldPercentage of Votes
in Favour
Raymond Lai23,289,1133,603,289
(13.399%)
86.601%
Daniel Chu23,750,0883,142,314
(11.685%)
88.315%
Joe Wong25,169,7591,722,643
(6.406%)
93.594%
Naj Alizada23,443,3293,448,073
(12.822%)
87.178%
Greg Moline24,809,4112,082,991
(7.746%)
92.254%
Terence Lam25,221,7281,670,674
(6.212%)
93.788%
Daniel Larkin25,321,6281,570,764
(5.841%)
94.159%
    

All other matters set out in the management information circular, dated May 15, 2018 were approved by the requisite majority of the shareholders at the annual general meeting of shareholders. Detailed voting results for the meeting are available on SEDAR at www.sedar.com.

For further information regarding the Company, please visit www.mlgreenworld.com.  

About Maple Leaf Green World Inc.

Maple Leaf is a public Canadian company that focuses on the cannabis industry in North America. The Company currently operates cannabis projects in British Columbia and Nevada. With over ten years of extensive greenhouse management experience, the Company applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free organic cannabis products. Maple Leaf's long-term objective is to produce cannabis oil and to export its products to approved countries. The Company's common shares are listed for trading on the Aequitas NEO Exchange Inc. under the symbol "MGW" and on the OTCQB market under the symbol "MGWFF".

  
For further information, please contact:
  
Maple Leaf Green World Inc.
Raymond Lai, Chairman, President & CEO
+1(403) 452-4552
[email protected];
www.mlgreenworld.com
Big Reach Media, Inc. (Investor Relations)
Dale Shirley
Phone: (780) 632-6963; Mobile: (780) 964-4732
[email protected];
http://www.bigreachmedia.com

 


These press releases may also interest you

at 08:53
Alera Health, a leader in population health management integrating behavioral healthcare, is proud to announce its recognition as one of the Great Employers to Work for in North Carolina by Best Companies Group. The 2024 Great Employers to Work for...

at 08:45
Zinzino (publ) announces that the company's annual report for 2023 in Swedish is now published on the company's website, zinzino.com. The English version will be published within approximately 45 days. The 2024 Annual General Meeting will be held at...

at 08:38
Empower Community Care, a leading global behavioral health and education organization, is thrilled to announce that it has been honored with the prestigious Pacesetter Award for 2024. Presented annually by the Atlanta Business Chronicle, the...

at 08:35
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...

at 08:35
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice...

at 08:33
1MD Nutrition, a leading developer of physician-formulated, condition-specific nutritional supplements with key ingredients in therapeutically significant dosages from substantiated, human clinical trials, is now a "Proud Partner" of the...



News published on and distributed by: